Although further studies are required to determine the underlying mechanisms in a synergistic effect between gemcitabine and B7-H3 blockade, our data may be clinically important and support future application of B7-H3 blockade for the treatment of pancreatic cancer. The gene discussed is CD276; the disease is familial pancreatic carcinoma.